| 1 |
Antihyperglycemic, Antihyperlipidemic and Cardioprotective Profile of Bromocriptine, Glibenclamide and Metformin Combination in Dexamethasone-induced Hyperglycemic Rats |
|
| | Adejuwon Adewale Adeneye,Joseph Abayomi Olagunju | | | Pharmacologia. 2012; 3(12): 665 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Nanoparticulate lipid dispersions for bromocriptine delivery: Characterization and in vivo study |
|
| | | | | European Journal of Pharmaceutics and Biopharmaceutics. 2011; | | | [HTML Full text] [Google Scholar] [DOI] | | | 3 |
Bromocriptine mesylate for glycemic management in type 2 diabetes mellitus |
|
| | Kerr, J.L., Timpe, E.M., Petkewicz, K.A. | | | Annals of Pharmacotherapy. 2010; 44(11): 1777-1785 | | | [Pubmed] [Google Scholar] | | | 4 |
A systematic account of pathogenesis, diagnosis and pharmacotherapy of metabolic syndrome: Things we need to know |
|
| | Mahajan, R., Gupta, K., Kapoor, V. | | | International Journal of Pharmacology. 2010; 6(4): 430-437 | | | [Pubmed] [Google Scholar] | | | 5 |
A Systematic Account of Pathogenesis, Diagnosis and Pharmacotherapy of Metabolic Syndrome: Things We Need to Know |
|
| | R. Mahajan, K. Gupta, V. Kapoor | | | International Journal of Pharmacology. 2010; 6(4): 338 | | | [HTML Full text] [Google Scholar] [DOI] | |
|
